AHA Coding Clinic® for HCPCS - 2009 Issue 2; FOR your INFORMATION

New HCPCS Code

Certolizumab pegol, trade name Cimzia, is a therapeutic monoclonal antibody utilized in the treatment of Crohn’s disease. It is administered via subcutaneous injections in the abdomen or thigh. This drug was approved by the Food and Drug Administration on April 22, 2008. A new HCPCS code was created by CMS for the certolizumab pegol injection. This code became effective April 1, 2009. HCPCS—Long Descriptor CodeC9249—Injection, certolizumab pegol, 1 mg As a reminder, report units of service based on the HCPCS code long descriptor and the dosage used for the patient. In addition always check the HCPCS...

To read the full article, sign in and subscribe to the AHA Coding Clinic® for HCPCS.


The AHA Coding Clinic for HCPCS includes:

  • The official publication for Level I HCPCS (CPT-4 codes) for hospital providers
  • Also specific Level II HCPCS codes for hospitals, physicians and other health professionals
  • Current newsletters added each quarter
  • Full Archives back to 2001
  • Fully searchable through Find-A-Code's Comprehensive Search
  • Codes mentioned in articles are linked to Code Information pages
  • Code Information page link back to related articles
  • View all the articles associated with any code, right from the code page!
Access to this feature is available in the following products:
  • AHA's Coding Clinic® - HCPCS +Archives

demo
request yours today
 subscribe
start today
 newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.